STING agonist combined with Vps34 inhibitor results in markedly reduced tumour size STING agonist combined with Vps34 inhibitor results in markedly reduced tumour size April 2024 Science Read more
2021 February General Immuno-oncology choices and therapy management in metastatic renal cell carcinoma Read more